Call for Abstract
Scientific Program
10th Asia-Pacific Pharma Congress, will be organized around the theme “De Novo Advancements in Pharmaceutical Sciences”
Asia Pharma 2017 is comprised of 20 tracks and 105 sessions designed to offer comprehensive sessions that address current issues in Asia Pharma 2017.
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
Regulatory Affairs contributes essentially to the overall success of drug development, both at early pre-marketing stages and at all times post-marketing. The pharmaceutical industry deals with an increasing number of interesting drug candidates, all of which necessitate the involvement of the quality assurance in regulatory affairs department.
The regulatory affairs outsourcing market has been segmented into five major service segments: regulatory affairs; clinical trial applications and product registrations; regulatory writing and publishing; regulatory consulting and legal representation; and others. The market segments have been extensively analysed on the basis of their usefulness, efficacy, generated revenue and geographic coverage. The market size and forecast in terms of USD million for each service type has been provided for the period from 2012 to 2020, considering 2013 as the base year. The report also provides the compounded annual growth rate (CAGR %) for each market segment for the forecast period from 2014 to 2020.
- Track 1-1Drugs and Regulations
- Track 1-2Regulations and Organizations
- Track 1-3Good Governance in Pharmacy
- Track 1-4Health Care Management and Providers
- Track 1-5Clinical Pharmacy Services: Patient Compliance
The importance of intellectual property law is well established at all levels-statutory, administrative and judicial. It lays down minimum standards for protection and enforcement in member countries which are required to promote effective and adequate protection of intellectual property rights with a view to reducing distortions and impediments to international trade.
The Agreement provides norms and standards in respect of following areas of intellectual properties are Patents, Trademarks, copyrights, Geographical indications, Industrial designs.
The global intellectual property market will move a step close to maturity when IP laws are followed, information transparency is achieved, and strategic thinking is given importance. Leading economies have already passed laws to encourage this. In the United States, for instance, introduced the America Invents Act in September 2011. The act is aimed at enhancing product quality by collecting third party patent-related information and registering it with the United States Patent and Trademark Office (USPTO).
- Track 2-1Intellectual Property Law for Generics and Innovator Rights
- Track 2-2Safety and Quality Regulation in Labelling
- Track 2-3Quality, Safety and Efficacy Issues
- Track 2-4Patents in Pharmaceutical Industry: Legal and Ethical Issues
- Track 2-5Global Pharma Products Registration
Although most pharmacognostic studies focus on plants and medicines derived from plants, other types of organisms are also regarded as pharmacognostically interesting, in particular, various types of microbes (bacteria, fungi, etc.), and recently various marine organisms.
Medical Ethnobotany: The study of the traditional use of plants for medicinal purposes
Ethnopharmacology: The study of the pharmacological qualities of traditional medicinal substances
Phytotherapy: The study of medicinal use of plant extracts
Phytochemistry: The study of chemicals derived from plants (including the identification of new drug candidates derived from plant sources).
Zoopharmacognosy: The process by which animals self-medicate, by selecting and using plants, soils, and insects to treat and prevent disease.
Marine Pharmacognosy: The study of chemicals derived from marine organisms.
It is estimated that about 70% of the supply of herbal raw material for Ayurveda and other homeopathic medicines in India comes from the wild. The global market for botanical and plant-derived drugs was valued at $23.2 billion in 2013 and $24.4 billion in 2014. This total market is expected to reach $25.6 billion in 2015 and nearly $35.4 billion in 2020, with a compound annual growth rate (CAGR) of 6.6% from 2015 to 2020.
- Track 3-1Drug Discovery Research in Pharmacognosy
- Track 3-2Drugs from Natural Sources
- Track 3-3Industrial Pharmacognosy
- Track 3-4Herbal Drug Analysis Methods
- Track 3-5Pharmacoergasy
- Track 3-6Ethnopharmcology
- Track 3-7Telemedicine
- Track 3-8Natural Products of Medicinal Interest
It encompasses a molecular evaluation of drug metabolism and transport processes and the study of genetic, environmental and disease-related factors that regulate or perturb those processes, as well as the fundamental mathematical relationships between enzyme/transporter function, blood concentration-time profiles and the spectrum of pharmacological effects.
The global market for contract pharmaceutical manufacturing, research and packaging totalled $248.5 billion in 2014 and is projected to approach $352.8 billion by 2019, registering a compound annual growth rate (CAGR) of 7.3% through 2019.
- Track 4-1Pre-formulation Considerations
- Track 4-2Drug Safety
- Track 4-3Pharmaceutics and Drug Delivery
- Track 4-4Pharmaceutical Technology
- Track 4-5Radiopharmaceuticals
- Track 4-6Nanotechnology in Drug Delivery Systems
- Track 4-7Sustained Drug Delivery System
- Track 4-8Recent Advances in Drug Delivery System
- Track 4-9Advances in pharmacodynamics & Pharmacokinetics
It is a part of science and technology about the control of matter on the atomic and molecular scale - this means things that are about 100 nanometres or smaller.
Nanotechnology brings together scientists and engineers from many different subjects, such as applied physics, materials science, interface and colloid science, device physics, chemistry, Supramolecular chemistry (which refers to the area of chemistry that focuses on the non-covalent bonding interactions of molecules), self-replicating machines and robotics, chemical engineering, mechanical engineering, biology engineering, and electrical engineering.
The global market for nanotechnology was valued at $22.9 billion in 2013 and increased to about $26 billion in 2014. This market is expected to reach about $64.2 billion by 2019, a compound annual growth rate (CAGR) of 19.8% from 2014 to 2019.
- Track 5-1Nanobiomaterials and Biopharmaceuticals
- Track 5-2Bionanotechnology
- Track 5-3Nanotechnology in Cancer Research
- Track 5-4Nanotechnology in Drug Delivery System
- Track 5-5Engineering of Pharmaceutical Nanosystems
Industrial pharmacy is a discipline which includes manufacturing, development, marketing and distribution of drug products including quality assurance of these activities.
The research topics are focussed on solving current general problems in pharmaceutical industry, such as formulation and characterisation of sticky amorphous drugs, problem-solving for paediatric medicines and miniaturisation of manufacturing processes.
The drugs fulfil the promise of modern medicine by enriching and often extending a patient’s quality of life Specialty pharmaceutical spending is on the rise and is expected to increase from approximately $55 billion in 2005 to $1.7 trillion in 2030, according to the Pharmaceutical Care Management.
- Track 6-1Drug Discovery and Development
- Track 6-2Industrial Pharmaceutics
- Track 6-3Pre-clinical Studies
- Track 6-4Clinical Studies
Pharmacology is the study of how medicine and other things have an effect on living organisms and change how they function. The field encompasses drug composition and properties, synthesis and drug design, molecular and cellular mechanisms, organ/systems mechanisms, signal transduction/cellular communication, molecular diagnostics, interactions, toxicology, chemical biology, therapy, and medical applications and anti-pathogenic capabilities.
The global pharmacology market was valued at $346.2 million in 2013 and $360.9 million in 2014. This market is expected to grow to $412.7 million by 2019, a compound annual growth rate (CAGR) of 2.7%.
- Track 7-1Clinical Pharmacology & Toxicology
- Track 7-2Cardiovascular Pharmacology
- Track 7-3Neuro-Pharmacology
- Track 7-4Pharmacoepidemiology and Drug Safety
- Track 7-5Immune-Pharmacology
- Track 7-6Translational Pharmacology & Oncopharmacology
- Track 7-7Pharmacological Drug Discovery
- Track 7-8Clinical Trails and Guidelines for Clinical Research
Pharmaceutical Chemistry is a core discipline within Pharmaceutical Sciences. It is centrally engaged in the drug discovery process, mainly focusing on lead finding, lead optimisation and structure-activity relationship investigations, using technologies of computer-aided drug design, natural products chemistry, synthetic organic chemistry, and biochemical molecules approaches in a trans-disciplinary combination which is generally known by the term "Medicinal Chemistry".
The pharmaceutical market was valued at $1 trillion in 2013, according to IMS. The market grew at a 4% compound annual growth rate (CAGR) from 2009 to 2013. It grew well in 2010 and 2011 before a decline in growth in 2012 and 2013.
- Track 8-1Chemistry of Natural Products
- Track 8-2Advanced Medicinal Chemistry
- Track 8-3Advances in Pharmaceutical Organic Chemistry
- Track 8-4Molecular Drug Design
- Track 8-5Green Techniques for Organic Synthesis and Medicinal Chemistry
- Track 8-6Advances in Drug Discovery
- Track 8-7Computational Chemistry
Pharmaceutical analysis is a process or a sequence of processes to identify and/or quantify a substance or drug, the components of a pharmaceutical solution or mixture or the determination of the structures of chemical compounds used in the formulation of pharmaceutical product. This is mainly used for the separation of the components from the mixture and for the determination of the structure of the compounds.
The global revenue of the market research industry exceeded 40 billion U.S. dollars in 2013, rising year-on-year since it experienced a slight dip in 2009 during the Great Recession. In 2013, Europe generated the largest share of market research revenue at 40 percent, or 16 billion U.S. dollars, very closely followed by North America with 39 percent. Despite contributing the most revenue that year, Europe also saw the largest decline in revenue over the previous year, falling by 1.4 percent.
- Track 9-1Novel Approaches to Analytical and Bioanalytical Methods
- Track 9-2Bioanalytical Techniques
- Track 9-3Chromatography and Techniques
- Track 9-4Spectroscopic Techniques
- Track 9-5Nuclear Magnetic Resonanace
- Track 9-6Mass Spectroscopy
- Track 9-7Regulatory Issues and Biosafety Challenges in Bioanalysis
- Track 9-8Applications of Analytical and Bioanalytical Methods
It includes the research and development of anti-infective agents, the use of microorganisms to detect mutagenic and carcinogenic activity in prospective drugs, and the use of microorganisms in the manufacture of pharmaceutical products like insulin and human growth hormone.
Pharmaceutical microbiology is additionally involved with the validation of disinfectants, according to standards, to evaluate the efficacy of disinfectants in suspension, on surfaces, and through field trials.
The consumables, equipment and technology markets in the microbiology industry totalled nearly $7.7 billion in 2012. This total is expected to grow from $8.5 billion in 2013 to $11.4 billion in 2018, with a compound annual growth rate (CAGR) of 6.1% for the five-year period, 2013 to 2018.
- Track 10-1Globalization and Standardized Pharmacopoeia
- Track 10-2Critical Microbiology Quality Attributes for Intermediates, APIs, Excipients, and Drug Substance
- Track 10-3Biological/biopharmaceutical Manufacturing
- Track 10-4Antimicrobial Activity and Disinfection
- Track 10-5Appropriate Strategies for Maintaining a non-sterile Manufacturing Environment
- Track 10-6Local Regulatory and Pharmacopoeial Expectations
Pharmaceutical biotechnology has emerged as one of the major disciplines for drug discovery and development. Today the shape and vision of pharmaceutical aspects and challenges have completely changed, and the prefix “pharma” can also be accepted as a synonym for integrated life science approaches, ranging from genetics to molecular biology to diagnostics, with the common goal of delivering the best drug to the patient by biotechnological techniques.
Global market for biotechnology in the life sciences is estimated at over $29.6 billion for 2014. Pharmaceutical Biotechnology will show steady sustained growth at 20.7%. This market is forecast to grow to more than $79.8 billion by 2019 to register a healthy compound annual growth rate (CAGR) of 22%.
- Track 11-1Biofuels
- Track 11-2Tissue Engineering
- Track 11-3Genomics and Proteomics
- Track 11-4Biomedical Data Engineering
- Track 11-5Industrial Pharma Biotechnology
- Track 11-6Bioinformatics Engineering
- Track 11-7Genetics & Genetic Engineering
By controlling information flow through biochemical signalling and the flow of chemical energy through metabolism, biochemical processes give rise to the complexity of life. Over the last 40 years, biochemistry has become so successful at explaining living processes that now almost all areas of the life sciences from botany to medicine are engaged in biochemical research.
Today, the main focus of pure biochemistry is in understanding how biochemical molecules give rise to the processes that occur within living cells, which in turn relates greatly to the study and understanding of whole organisms. Biochemistry has advanced, especially since the mid-20th century, with the development of new techniques such as chromatography, X-ray diffraction, dual polarisation interferometry, NMR spectroscopy, radio isotopic labelling, electron microscopy, and molecular dynamics simulations. These techniques allowed for the discovery and detailed analysis of many molecules and metabolic pathways of the cell, such as glycolysis and the Krebs cycle.
The report analyses the worldwide markets for Laboratory Chemical Reagents in US$ Million by the segments like Biochemistry and Molecular Biology. Annual estimates and forecasts are provided for the period 2013 through 2020. Employment of biochemists and biophysicists is projected to grow 8 percent from 2014 to 2024, about as fast as the average for all occupations.
- Track 12-1Immunochemistry
- Track 12-2Computational Chemistry
- Track 12-3Biomolecules
- Track 12-4Molecular Drug Design
- Track 12-5Protein Biosynthesis, Protein Folding and Global Protein Analysis and Function
- Track 12-6Immunochemistry
- Track 12-7Structure Activity Relationship
Recognition of the practice of clinical pharmacy by the profession has led to our professional bodies publishing statements aimed at standardising pharmacy practice. These statements were developed by the profession to bring uniformity to the practice of clinical pharmacy. However they outlined what pharmacists want from clinical pharmacy, there was little input from clinical colleagues or patients about what they wanted from clinical pharmacy.
The global clinical pharmacy market reached nearly $3.0 billion in 2012. This market is expected to grow to nearly $3.2 billion in 2013 and $4.9 billion in 2018 with a compound annual growth rate (CAGR) of 8.8% over the five-year period, 2015 to 2020. Clinical pharmacy has a rich history of advancing practice through innovation.
- Track 13-1Role of Clinical Pharmacist
- Track 13-2Dosage Regimen, Drug Toxicity and Drug Safety Measures
- Track 13-3Pharmacoepidemiology of Drug Shortages
- Track 13-4Clinical Pharmacy and Community Pharmacy
- Track 13-5Pharmacovigilance
- Track 13-6Pharmacoeconomics
The study of pharmacy involves the effective recommendation and administration of various medications for the safety and health of patients. Hospital pharmacy is a specialization of this field that includes additional duties such as aiding doctors in applying drug therapy. The statements were developed by the profession to bring uniformity to the practice of hospital pharmacy.
Emergency department visits accounted for 7.4% of the total hospital visits in the U.S. in 2011 compared to 2.3% in 2010. Global spending on medicines is expected to increase from USD 1 trillion in 2014 to USD 1.2 trillion by 2017. Asia Pacific and Rest of the World are among the fastest growing markets for hospital pharmaceuticals due to the presence of large population base, aging population suffering from chronic diseases and increasing disposable income.
- Track 14-1Role of Hospital Pharmacist
- Track 14-2Pharmaceutical care
- Track 14-3Ethics in Pharmacy
- Track 14-4Pharmacy Practice
- Track 14-5Challenges in Compounding and Dispensing Practice
The pharmaceutical industry has provided the world with incredible medical breakthroughs. Although science continues to outpace the law, it is imperative that compliance infrastructures remain current. Effective compliance programs continue to be top of mind for industry stakeholders. It is important that compliance programs continue to ensure that training programs are designed to effectively train management including the directors of life sciences companies.
The global pharmaceutical packaging equipment market is estimated to grow at a CAGR of 6.9% from 2015 to 2020 to reach USD 7.24 Billion by 2020. Growth in the generics market, the rising need for novel and flexible packaging equipment, growing offshore manufacturing of the pharmaceutical packaging equipment, growth of contract manufacturing and regulatory compliance mandating the replacement of old equipment are some major factors driving the growth of this market.
- Track 15-1Regulatory Compliance
- Track 15-2Risk Management
- Track 15-3Patient Compliance
- Track 15-4Data Integration
Pharmaceutical Care is a patient-centered, outcomes oriented pharmacy practice that requires the pharmacist to work in concert with the patient and the patient's other healthcare providers to promote health, to prevent disease, and to assess, monitor, initiate, and modify medication use to assure that drug therapy regimens are safe and effective.
A good health system delivers quality services to all people, when and where they need them. The exact configuration of services varies from country to country, but in all cases requires a robust financing mechanism; a well-trained and adequately paid workforce; reliable information on which to base decisions and policies; well maintained facilities and logistics to deliver quality medicines and technologies.
- Track 16-1Pharmacy Education
- Track 16-2Pharmaceutical Care Practice
- Track 16-3Pharmaceutical Care Management
- Track 16-4Clinical Management Systems
- Track 16-5Medication Management Services
- Track 16-6Medical Billing Softwares
Functional food and nutraceutical items speak to esteem included development open door for the agri-food industry, both locally and universally. The market is driven by the maturing populace, rising social insurance costs, propels in nourishment innovation and sustenance, and in addition a developing customer comprehension of the connection amongst eating regimen and wellbeing. Nutraceuticals have additionally discovered impressive trust in treating cerebral pains and headaches coming about because of stress. Other related nutraceutical items are touted as cures for diminishing hair, absence of certainty, poor composition, varicose veins, liquor abuse, despondency, and torpidity.
The nutraceuticals industry is now expending billions of dollars each year for the purchase of health-related foods and supplements. The respective health benefits are based on science and ethics, for health claims for functional foods, and presence of certain phytochemicals. The global nutraceuticals market is expanding at a CAGR of 7.3% from 2015 to 2021, according to Transparency Market Research. This market was already valued at US$182.6 billion in 2015, which means that it can go up to US$278.95 billion by the end of 2021.
- Track 17-1Herbal & Traditional Medicine
- Track 17-2Natural Medicine Products
- Track 17-3Nutraceuticals in Cancer Therapy
- Track 17-4Prebiotics & Probiotics
- Track 17-5Dietary Supplements & Functional Foods
World pharmaceutical market is worth US$300 billion a year, a figure expected to rise to US$400 billion within three years. The pharmaceutical industry is responsible for the development, production and marketing of medications. Thus, its immense importance as a global sector is evident. More than any other industry, the pharmaceutical sector is highly dependent on its research and development segment. Pharmaceutical companies invest 20 percent and more of their revenues in R&D measures. The United States is a traditional stronghold of pharmaceutical innovation.
The worldwide revenue of the pharmaceutical market from 2001 to 2014 was around 390.2 billion U.S. dollars. Ten years later, this figure stood at almost one trillion U.S. dollars. In 2008, global pharmaceutical revenue came to some 712 billion U.S. dollars based on quarterly exchange rates. Six years later, total revenues of the pharmaceutical market stood at almost 940 billion U.S. dollars worldwide.
Asia Pacific is the third largest pharmaceutical market in the world after North America and Europe, with generics being the major driver for the pharmaceutical industry in this region, aided by factors such as the aging population and impending expiry of patented drugs. BMI's pharmaceutical expenditure forecasts show that, in general, developing countries will see a higher rate of pharmaceutical sales growth, while the growth for developed countries is lower. Countries that will experience strong growth include Vietnam (16.4%), China (15.0%), Sri Lanka (12.4%), Myanmar (12.2%) and Bangladesh (11.5%).
Pharmaceuticals mount the lion share in terms of volume, having evolved into a US $959 billion industry that generates more than 60 percent of the segment with growth expected to reach to 5.3 percent per annum between 2012 and 2017 (IMS 2013). Combined sales of prescription drugs and over-the-counter (OTC) medicines are forecast to increase from USD276.6bn in 2013 to USD384.7bn in 2018, representing a five-year compound annual growth (CAGR) of 7.0%.
A platform aimed to connect Entrepreneurs, Proposers and the Investors worldwide. It's intended to create and facilitate the most optimized and viable meeting place for engaging people in global business discussions, evaluation and execution of promising business ideas. An investor could be able to find out the highest potential investment opportunities globally, which provide good return on investment. For entrepreneurs, this would be an ideal place to find out suitable investors and partners to start and/or expand their business. Thus it is a perfect place to connect Entrepreneurs, Business Owners, Early Stage Companies and Established Corporates with National or International Investors, Corporate Investors and Potential Business Partners.